Dapagliflozin in PRESERVED Ejection Fraction Heart Failure

Clinical trial NCT03030235 · COMPLETED

Trial details

NCT number: NCT03030235
Sponsor: Saint Luke's Health System
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Heart Failure With Preserved Systolic Function

Start date: 2017-03-01
Primary completion: 2021-08-13
Enrollment: 324

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.